🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Italy / NCT07483905
Starting soon Observational

Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients

NCT07483905 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2026-03-12
Last updated
2026-03-19

Condition(s) studied

Gynecologic Cancers

Investigational drug(s) / intervention(s)

online survey

online survey: Participants will complete an anonymous online survey designed to assess their interest in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions.

Study summary

This observational study aims to assess the interest of patients with gynecologic cancers in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions. An anonymous online survey will be distributed to eligible patients to evaluate their preferences, perceived benefits, and potential barriers related to receiving chemotherapy during nighttime hours. The results of this study will help inform the feasibility and acceptability of implementing a nighttime Day Hospital service for prolonged chemotherapy infusions.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Female patients * aged 18 years or older * Diagnosis of a gynecologic cancer * Receiving care at the participating institution * Ability to independently understand and complete complete the anonymous online survey Exclusion Criteria: * Inability to access or complete the online questionnaire or difficulty with reading and writing * Cognitive impairment * Patients currently hospitalized or in emergency settings.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07483905 on ClinicalTrials.gov ↗ ← All trials in Italy